These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5298476)

  • 41. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 42. Current management of respiratory tuberculosis.
    Ormerod P
    Br J Hosp Med; 1987 Apr; 37(4):304-8. PubMed ID: 3580684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tuberculosis, does it always come out right?].
    Steensma JT
    Ned Tijdschr Geneeskd; 1986 Jan; 130(4):145-7. PubMed ID: 3513030
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sanatorium for lung diseases in Zamberk. Results of treatment with antitubercular drugs of the 2d group in 290 patients resistant to 2-3 drugs of the 1st group].
    Mydlil F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(5):523-34. PubMed ID: 5243152
    [No Abstract]   [Full Text] [Related]  

  • 45. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 47. [The follow-up study of the ambulatory chemotherapy for pulmonary tuberculosis. VII. II. Analysis on the radiological aggravation during and after cessation of chemotherapy].
    Kekkaku; 1966 Mar; 41(3):115-9. PubMed ID: 5965453
    [No Abstract]   [Full Text] [Related]  

  • 48. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

  • 49. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
    Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
    Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
    [No Abstract]   [Full Text] [Related]  

  • 50. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
    Cowie RL; Langton ME; Escreet BC
    S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 52. The John Barnwell lecture: Improving existing methods of control of tuberculosis: A prime challenge to the experimentalist.
    Schmidt LH
    Am Rev Respir Dis; 1972 Feb; 105(2):183-205. PubMed ID: 4621610
    [No Abstract]   [Full Text] [Related]  

  • 53. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
    Kumar L; Gupta R; Puri MM; Jaiswal A; Srinath ; Murar A; Behera D
    J Assoc Physicians India; 2011 Nov; 59():733-5. PubMed ID: 22616343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
    Grumbach F
    Bull Int Union Tuberc; 1968 Dec; 41():303-8. PubMed ID: 5710255
    [No Abstract]   [Full Text] [Related]  

  • 55. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
    Moulding T
    Int J Tuberc Lung Dis; 2000 May; 4(5):485-6. PubMed ID: 10815744
    [No Abstract]   [Full Text] [Related]  

  • 57. [Symposium on comparison of clinical efficacy among various kinds of chemotherapeutic regimens for pulmonary tuberculosis. 2. Results of studies by the Cooperative Study Unit on Chemotherapy of Tuberculosis in the national sanatorium].
    Shimamura K
    Kekkaku; 1966 Sep; 41(9):436-42. PubMed ID: 5975805
    [No Abstract]   [Full Text] [Related]  

  • 58. [Radiological or microbiological criteria of the efficacity of treatment in pulmonary tuberculosis].
    Krychniak W
    Gruzlica; 1972; 40(3):201-9. PubMed ID: 5020375
    [No Abstract]   [Full Text] [Related]  

  • 59. Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis.
    Bai KJ; Yu MC; Suo J; Chiang CY; Chiang IH; Lin TP; Luh KT
    J Formos Med Assoc; 1998 Apr; 97(4):278-82. PubMed ID: 9585680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The syndrome of open cavity healing.
    Zierski M
    Scand J Respir Dis Suppl; 1968; 65():151-6. PubMed ID: 4978459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.